AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldfield, G. S
Right arrow Articles by Doucet, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldfield, G. S
Right arrow Articles by Doucet, E.
Agricola
Right arrow Articles by Goldfield, G. S
Right arrow Articles by Doucet, E.
American Journal of Clinical Nutrition, Vol. 86, No. 2, 308-315, August 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food?1,2,3

Gary S Goldfield, Claudio Lorello and Éric Doucet

1 From Mental Health Research, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON (GSG); the School of Human Kinetics (GSG, CL, and ED), Department of Paediatrics (GSG), University of Ottawa, Ottawa, ON; and the Department of Psychology, Carleton University, Ottawa, ON (GSG)

Background: Dopamine mediates the reinforcing value of food, and low concentrations of dopamine are related to increased feeding. Thus, administering a drug that increases dopamine may reduce energy intake, possibly by reducing food reinforcement.

Objectives: We tested whether short-acting methylphenidate (MPH), a drug that increases the availability of dopamine by blocking its reuptake, reduces energy intake and alters macronutrient preference and whether these effects are due to a mechanism of reduced hunger or food reinforcement.

Design: Fourteen adults were given placebo or short-acting MPH (0.5 mg/kg) in a randomized, double-blind, placebo-controlled crossover fashion. One hour after ingestion, hunger and the relative reinforcing value of snack food were measured, followed immediately by energy intake and macronutrient preference during a buffet-style lunch.

Results: MPH reduced energy intake by 11% (P = 0.024) as well as intake of fat by 17% (P = 0.003) relative to placebo. Despite similar levels of prebuffet hunger, subjects taking MPH reduced their energy and fat intakes more than did those taking placebo, which suggests that hunger may not mediate the effects of MPH on energy intake. MPH showed a trend toward reducing the reinforcing value of high-fat food relative to placebo, but reduced food reinforcement was not significantly correlated with energy intake.

Conclusion: MPH reduced overall energy intake with a selective reduction in dietary fat. Findings are consistent with a reward deficiency model of obesity whereby low brain dopamine predicts overeating and obesity, and administering agents that increase dopamine results in reduced feeding behavior.

Key Words: Methylphenidate • dopamine • eating • energy intake • food reinforcement • obesity







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition